VF
NSPRZ

Virtu Financial’s InspireMD, Inc. Series B Warrants NSPRZ Stock Holding History

Virtu Financial’s Portfolio NSPRZ Stock Details NSPRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-41,152
Closed -$3K – 2460
2021
Q4 		$3K Sell
41,152
-10,891
-21% -$1.13K ﹤0.01% 1633
2021
Q3 		$6K Buy
52,043
+3,914
+8% +$557 ﹤0.01% 1424
2021
Q2 		$9K Buy
48,129
+24,681
+105% +$1.64K ﹤0.01% 1429
2021
Q1 		$1K Sell
23,448
-13,380
-36% -$634 ﹤0.01% 1543
2020
Q4 		$1K Buy
36,828
+1,714
+5% +$22 ﹤0.01% 1391
2020
Q3 		$0 Sell
35,114
-12,281
-26% -$169 ﹤0.01% 1727
2020
Q2 		$1K Buy
+47,395
New +$474 ﹤0.01% 1203
2018
Q1 		– Sell
-85,305
Closed – – 2852
2017
Q4 		$0 Buy
85,305
+16,033
+23% +$434 ﹤0.01% 3217
2017
Q3 		$0 Buy
+69,272
New +$5.91K ﹤0.01% 2522

Virtu Financial's NSPRZ Position: Q1 2022 in Review

Virtu Financial sold out of InspireMD, Inc. Series B Warrants (NSPRZ) in Q1 2022, closing a stake of 41,152 shares — an estimated $3K sold.

Virtu Financial first reported a position in NSPRZ in Q3 2017 and held it in 9 quarters. The position peaked at $9K in Q2 2021. 0 funds tracked by Wall St. Rank hold NSPRZ as of Q1 2022.

  • Virtu Financial reported no remaining InspireMD, Inc. Series B Warrants position as of Q1 2022 after selling out during the quarter.
  • Virtu Financial sold 41,152 InspireMD, Inc. Series B Warrants shares in Q1 2022, an estimated $3K.
  • Virtu Financial first reported a position in InspireMD, Inc. Series B Warrants in Q3 2017 and held it in 9 quarters.
  • Virtu Financial's InspireMD, Inc. Series B Warrants position peaked at $9K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held InspireMD, Inc. Series B Warrants as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.